Why Eagle Pharmaceuticals, Inc. Skyrocketed 27.8% Today – Motley Fool


Motley Fool
Why Eagle Pharmaceuticals, Inc. Skyrocketed 27.8% Today
Motley Fool
What: News of a positive court decision that could support sales growth led to shares in Eagle Pharmaceuticals (NASDAQ:EGRX) spiking 27.8% earlier today. So what: Following the licensing of its Bendeka to Teva Pharmaceutical (NYSE:TEVA), Eagle¬†…
Eagle Pharmaceuticals Inc (EGRX) Earns Buy Rating from MizuhoLet Me Know About This
Eagle Pharmaceuticals (EGRX) Marked As A Barbarian At The GateTheStreet.com
Top Gainer Stocks On Run: Eagle Pharmaceuticals Inc (NASDAQ:EGRX), Axiall Corp (NYSE:AXLL)NYSE Journal (press release)

all 15 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd